LINC01932

Across TCGA pan-cancer cohorts, LINC01932 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC01932 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01932 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01932 expression acts as an unfavorable survival marker, although some lineages such as COAD and HNSC show a favorable association.

COAD, KIRC, and THYM are the cancer types where LINC01932 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	IV	1.000	0.283	.001	77	view →
KIRC	OS	Tertile	All	0.540	0.666	.002	60	view →
THYM	OS	Tertile	All	0.774	1.000	<.001	43	view →
DLBC	DFS	Quartile	II,III,IV	0.433	0.939	.012	24	view →
HNSC	OS	Median	IV	0.803	0.656	.008	22	view →
LUSC	DFS	Quartile	II,III,IV	0.694	0.449	.012	20	view →
SKCM	OS	Quartile	III,IV	0.553	0.804	.005	17	view →
STAD	DFS	Quartile	All	0.552	0.675	.014	15	view →
KIRP	DFS	Tertile	All	0.301	0.645	.007	15	view →
ACC	OS	Tertile	II,III,IV	0.613	0.897	.034	15	view →
BRCA	DFS	Tertile	II,III,IV	0.656	0.476	.012	12	view →
UVM	OS	Tertile	All	0.365	0.734	.018	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC01932–COAD (OS)

Open the COAD breakdown →